Recruiting
Phase 1
Phase 2

Sponsor:

ImmunityBio, Inc.

Code:

NCT02138734

Conditions

Non-muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BCG+N-803( 50mg BCG/ Instillation+ N-803( 400 μg/instillation). )

BCG( 50mg/Instillation)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by ImmunityBio, Inc. on 2024-08-09.